Lydia Denworth is a New York-based science writer and author of I Can Hear You Whisper: An Intimate Journey through the Science of Sound and Language.

Lydia Denworth
Contributing writer
The Transmitter
From this contributor
The last two-author neuroscience paper?
Author lists on papers have ballooned, and it’s getting hard to discern contribution.
The promise of telehealth in autism diagnoses
The COVID-19 pandemic forced a reckoning, in which autism clinicians had to redefine best practices and expand how children are evaluated. The remote assessments they developed may help solve a persistent problem: the long wait families endure to get a diagnosis in the United States.

The promise of telehealth in autism diagnoses
The most personalized medicine: Studying your own child’s rare condition
A handful of scientists are committed to advancing research on the autism-related genetic conditions their own children have.

The most personalized medicine: Studying your own child’s rare condition
Owen’s odyssey: A year and a half after an autism diagnosis
This is part 2 of Owen’s story. It tracks his early progress in treatment for autism. Part 1 described his difficult path to a diagnosis.

Owen’s odyssey: A year and a half after an autism diagnosis
A quest for Quincy: Gene therapies come of age for some forms of autism
A gene therapy for Angelman syndrome stands at the forefront of efforts to treat autism-linked conditions that stem from single genes.

A quest for Quincy: Gene therapies come of age for some forms of autism
Explore more from The Transmitter
Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.

Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.

Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.

Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.